VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > VPTs Financials

<< Previous

Bullboard Posts

Next >>

Comment by WalkOverTheStrton Aug 29, 2023 9:56pm

79 Views

Post# 35611113

RE:VPTs Financials

Graham that is standard boiler plate verbiage most micro caps use in their filings....
We know sales are an issue but if you joined one of the investor calls Alvira has stated when they expect those POs/units to be accepted and the sales orders will ramp (Q4). I am not expecting anything of note until Q4. But if Q4 does not have a marketable (10-15+ sales) I will be concerned but again this was stated to occur two investor calls ago by Alvira. Do you join the investor calls?

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale